PNC Financial Services Group Inc. Grows Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

PNC Financial Services Group Inc. grew its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 11.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 67,988 shares of the medical instruments supplier’s stock after buying an additional 6,729 shares during the quarter. PNC Financial Services Group Inc.’s holdings in DENTSPLY SIRONA were worth $2,420,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of XRAY. VisionPoint Advisory Group LLC lifted its position in shares of DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 395 shares in the last quarter. Principal Securities Inc. acquired a new position in shares of DENTSPLY SIRONA during the fourth quarter worth $26,000. Headlands Technologies LLC acquired a new position in shares of DENTSPLY SIRONA during the fourth quarter worth $30,000. Parkside Financial Bank & Trust lifted its position in shares of DENTSPLY SIRONA by 33.3% during the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after purchasing an additional 292 shares in the last quarter. Finally, Anchor Investment Management LLC acquired a new position in shares of DENTSPLY SIRONA during the fourth quarter worth $47,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Performance

Shares of XRAY opened at $25.45 on Friday. The firm has a 50-day moving average price of $28.38 and a 200 day moving average price of $32.01. The firm has a market capitalization of $5.28 billion, a PE ratio of -57.84, a P/E/G ratio of 1.14 and a beta of 1.04. The company has a quick ratio of 0.97, a current ratio of 1.43 and a debt-to-equity ratio of 0.54. DENTSPLY SIRONA Inc. has a 52-week low of $25.25 and a 52-week high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.42. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The firm had revenue of $953.00 million during the quarter, compared to analyst estimates of $969.45 million. During the same quarter in the prior year, the firm posted $0.39 EPS. DENTSPLY SIRONA’s revenue was down 2.6% compared to the same quarter last year. On average, sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 2.03 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Stockholders of record on Friday, June 28th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.64 annualized dividend and a dividend yield of 2.51%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -145.45%.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 3,577 shares of DENTSPLY SIRONA stock in a transaction dated Friday, May 31st. The stock was bought at an average price of $27.95 per share, for a total transaction of $99,977.15. Following the transaction, the director now owns 58,374 shares in the company, valued at approximately $1,631,553.30. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.52% of the company’s stock.

Wall Street Analysts Forecast Growth

XRAY has been the topic of a number of recent research reports. Piper Sandler reissued a “neutral” rating and set a $32.00 target price (down from $35.00) on shares of DENTSPLY SIRONA in a research report on Friday, May 3rd. Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a report on Friday, May 3rd. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, May 3rd. The Goldman Sachs Group cut their price target on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a report on Monday, May 6th. Finally, Barrington Research cut their price target on shares of DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating on the stock in a report on Friday, May 3rd. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Moderate Buy” and an average price target of $35.22.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.